147 related articles for article (PubMed ID: 14699795)
21. Post-genomics and skin inflammation.
Braconi D; Bernardini G; Santucci A
Mediators Inflamm; 2010; 2010():. PubMed ID: 20886018
[TBL] [Abstract][Full Text] [Related]
22. Human keratinocytes respond to interleukin-18: implication for the course of chronic inflammatory skin diseases.
Wittmann M; Purwar R; Hartmann C; Gutzmer R; Werfel T
J Invest Dermatol; 2005 Jun; 124(6):1225-33. PubMed ID: 15955098
[TBL] [Abstract][Full Text] [Related]
23. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis.
Nomura I; Gao B; Boguniewicz M; Darst MA; Travers JB; Leung DY
J Allergy Clin Immunol; 2003 Dec; 112(6):1195-202. PubMed ID: 14657882
[TBL] [Abstract][Full Text] [Related]
24. Letter to Editor: Chemokine Network Involved in Inflammatory Skin Diseases.
Shaik-Dasthagirisaheb YB; Conti P
Ann Clin Lab Sci; 2015; 45(4):452-7. PubMed ID: 26275700
[TBL] [Abstract][Full Text] [Related]
25. Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: atopic dermatitis, psoriasis and skin mastocytosis.
Nedoszytko B; Sokołowska-Wojdyło M; Ruckemann-Dziurdzińska K; Roszkiewicz J; Nowicki RJ
Postepy Dermatol Alergol; 2014 May; 31(2):84-91. PubMed ID: 25097473
[TBL] [Abstract][Full Text] [Related]
26. Aberrant suprabasal P-cadherin expression in acanthotic but not psoriatic thickened epidermis.
Wakita H; Yamamoto Y; Furukawa F
Arch Dermatol Res; 2003 Apr; 295 Suppl 1():S71-4. PubMed ID: 12677438
[No Abstract] [Full Text] [Related]
27. CXCL16 and CXCR6 are upregulated in psoriasis and mediate cutaneous recruitment of human CD8+ T cells.
Günther C; Carballido-Perrig N; Kaesler S; Carballido JM; Biedermann T
J Invest Dermatol; 2012 Mar; 132(3 Pt 1):626-34. PubMed ID: 22113484
[TBL] [Abstract][Full Text] [Related]
28. Redox imbalance in T cell-mediated skin diseases.
Pastore S; Korkina L
Mediators Inflamm; 2010; 2010():861949. PubMed ID: 20847812
[TBL] [Abstract][Full Text] [Related]
29. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.
Sertznig P; Seifert M; Tilgen W; Reichrath J
Am J Clin Dermatol; 2008; 9(1):15-31. PubMed ID: 18092840
[TBL] [Abstract][Full Text] [Related]
30. Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis.
Ruzicka T; Simmet T; Peskar BA; Ring J
J Invest Dermatol; 1986 Feb; 86(2):105-8. PubMed ID: 3018086
[TBL] [Abstract][Full Text] [Related]
31. Cystatin M / E expression in inflammatory and neoplastic skin disorders.
Zeeuwen PL; van Vlijmen-Willems IM; Egami H; Schalkwijk J
Br J Dermatol; 2002 Jul; 147(1):87-94. PubMed ID: 12100189
[TBL] [Abstract][Full Text] [Related]
32. CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation.
Gombert M; Dieu-Nosjean MC; Winterberg F; Bünemann E; Kubitza RC; Da Cunha L; Haahtela A; Lehtimäki S; Müller A; Rieker J; Meller S; Pivarcsi A; Koreck A; Fridman WH; Zentgraf HW; Pavenstädt H; Amara A; Caux C; Kemeny L; Alenius H; Lauerma A; Ruzicka T; Zlotnik A; Homey B
J Immunol; 2005 Apr; 174(8):5082-91. PubMed ID: 15814739
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of the aryl hydrocarbon receptor in patients with chronic inflammatory skin diseases.
Kim HO; Kim JH; Chung BY; Choi MG; Park CW
Exp Dermatol; 2014 Apr; 23(4):278-81. PubMed ID: 24521260
[TBL] [Abstract][Full Text] [Related]
34. Up-regulation of interleukin-13 receptor alpha1 on human keratinocytes in the skin of psoriasis and atopic dermatitis.
Wongpiyabovorn J; Suto H; Ushio H; Izuhara K; Mitsuishi K; Ikeda S; Nakao A; Okumura K; Ogawa H
J Dermatol Sci; 2003 Oct; 33(1):31-40. PubMed ID: 14527737
[TBL] [Abstract][Full Text] [Related]
35. Differential expression of a human endogenous retrovirus E transmembrane envelope glycoprotein in normal, psoriatic and atopic dermatitis human skin.
Bessis D; Molès JP; Basset-Séguin N; Tesniere A; Arpin C; Guilhou JJ
Br J Dermatol; 2004 Oct; 151(4):737-45. PubMed ID: 15491412
[TBL] [Abstract][Full Text] [Related]
36. Comparative studies of keratins isolated from psoriasis and atopic dermatitis.
Thaler M; Fukuyama K; Epstein WL; Fisher KA
J Invest Dermatol; 1980 Aug; 75(2):156-8. PubMed ID: 6157751
[TBL] [Abstract][Full Text] [Related]
37. Keratinocyte Expression of A20/TNFAIP3 Controls Skin Inflammation Associated with Atopic Dermatitis and Psoriasis.
Devos M; Mogilenko DA; Fleury S; Gilbert B; Becquart C; Quemener S; Dehondt H; Tougaard P; Staels B; Bachert C; Vandenabeele P; Van Loo G; Staumont-Salle D; Declercq W; Dombrowicz D
J Invest Dermatol; 2019 Jan; 139(1):135-145. PubMed ID: 30118730
[TBL] [Abstract][Full Text] [Related]
38. Skin Barrier Function: The Interplay of Physical, Chemical, and Immunologic Properties.
Baker P; Huang C; Radi R; Moll SB; Jules E; Arbiser JL
Cells; 2023 Nov; 12(23):. PubMed ID: 38067173
[TBL] [Abstract][Full Text] [Related]
39. Modulation of chemokines by staphylococcal superantigen in atopic dermatitis.
Homey B; Meller S; Savinko T; Alenius H; Lauerma A
Chem Immunol Allergy; 2007; 93():181-194. PubMed ID: 17369706
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-17 in inflammatory skin disorders.
van Beelen AJ; Teunissen MB; Kapsenberg ML; de Jong EC
Curr Opin Allergy Clin Immunol; 2007 Oct; 7(5):374-81. PubMed ID: 17873575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
